Vanda Pharmaceuticals
VNDA
VNDA
189 hedge funds and large institutions have $389M invested in Vanda Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+12
Holders Change %
+6.78%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
76
Reduced
52
Closed
16
Calls
$354K
Puts
$420K
Net Calls
-$66K
Net Calls Change
-$717K
Top Buyers
1 |
1
Millennium Management
New York
|
$13.2M |
2 |
2
BlackRock
New York
|
$76.3M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$4.05M |
4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$2.41M |
5 |
5
Federated Hermes
Pittsburgh,
Pennsylvania
|
$5.94M |